Skip to content
Sign inOpen the app
Pharmaceutical Executive

Pharmaceutical Executive Daily: Pathos AI Enters Two lIcensing Deals

Tuesday · 3 min · 3.3 MB
0:00-3:25

Streams straight from the publisher. podnod never proxies or re-hosts episode audio.

Open in podnod

In today's Pharmaceutical Executive Daily, Pathos AI signs licensing deals with Alphamab Oncology and AstraZeneca while Curium agrees to acquire Lantheus for up to $8 billion, Sandoz agrees to a $450 million settlement with 43 U.S. states over generic drug antitrust claims, and a new analysis argues real-time data analytics are essential to managing the growing data burden in clinical trials.